Two Sigma Investments’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,229
Closed -$14K 4588
2025
Q4
$14K Buy
+11,229
New +$15.3K ﹤0.01% 4016

Other funds holding BCDA

Two Sigma Investments's BCDA Position: Q1 2026 in Review

Two Sigma Investments sold out of BioCardia (BCDA) in Q1 2026, closing a stake of 11,229 shares — an estimated $14K sold.

Two Sigma Investments first reported a position in BCDA in Q4 2025 and held it in 1 quarter. The position peaked at $14K in Q4 2025. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Two Sigma Investments reported no remaining BioCardia position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 11,229 BioCardia shares in Q1 2026, an estimated $14K.
  • Two Sigma Investments first reported a position in BioCardia in Q4 2025 and held it in 1 quarter.
  • Two Sigma Investments's BioCardia position peaked at $14K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.